ArticleMolecular genetics and metabolism reports2022

Safety of a protocol for reduction of agalsidase beta infusion time in Fabry disease: An Italian multi-centre study.

Renzo Mignani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.